Chain Pharmacy

We can learn from New Zealand, Japan, and Pakistan

In 2012, FDA achieved a milestone with the approval of 39 innovative drug therapies for populations in need.

After years of declining pipeline productivity, are we headed for a resurgence in new approvals? Here's a look at what's ahead for 2013.

Intravenous abuse of Opana ER may be at risk of thrombotic thrombocytopenic purpura according to a report published in MMWR.

According to the numbers, at-home test kits are going to continue to be an area of market growth.

A new bimonthly column from Ken Baker looks at ethical decision-making in pharmacy.

NSAIDs plus ACE inhibitors or ARBs can increase risk of kidney injury for patients taking diuretics.

Recent data were released on a long-term, open-label extension study evaluating clobazam for the adjunctive treatment of drop seizures.

Pharmacy techs speak out.

Are pharmacists losing the love?

CMS recently approved 106 new ACOs in Medicare, including three of Walgreens' health networks.

Healthcare professionals can now report errors and near-misses that are associated with vaccine administration.

How do we empower patients who do not want drug therapy to take their routine medications? Actually, one simple tweak can make all of the difference. We tell them ‘why’ they are taking the medication.

The time has come for pharmacists to be considered healthcare providers under the Social Security Act.